| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 137, Issue 9 2937-2944, Copyright © 1986 by American Association of Immunologists
ARTICLES |
JS McDougal, JK Nicholson, GD Cross, SP Cort, MS Kennedy and AC Mawle
Human immunodeficiency virus (HIV), the retrovirus that causes the acquired immunodeficiency syndrome, is cytopathic for CD4+ T cells and binds to these cells via a complex of the 110,000 m.w. viral-envelope glycoprotein, gp110, and the CD4 molecule. We treated virus with several physical, chemical, and enzymic agents to determine their effect on the capacity of HIV to bind to the CD4+ T cell line, CEM. Reduction and alkylation (but not alkylation alone) and trypsin digestion (but not glycolytic enzyme digestions) of HIV destroyed its capacity to bind. If the tertiary protein structure conferred by disulfide bonding is not disrupted, the tertiary and secondary conformations dependent on noncovalent forces appear to be thermodynamically favored, because treatment with denaturants such as sodium dodecyl sulfate, 8 M urea, alcohol, or heat (56 degrees C or 65 degrees C for 30 min) followed by removal of the denaturants did not affect binding. Irreversible denaturation and loss of binding occurred after heating at 100 degrees C for 10 min. HIV binding to CD4+ T cells was inhibited either by murine monoclonal antibodies to the CD4 molecule or by human polyclonal or murine monoclonal antibodies to the gp110 molecule. On the basis of results of binding inhibition obtained with a panel of alpha-CD4 monoclonal antibodies, the receptor site for virus on the CD4 molecule was mapped to the amino-terminal portion of the molecule. Four candidate alpha-CD4 monoclonal antibodies that were potent inhibitors of virus binding (OKT4A, OKT4D, OKT4F, and Leu-3a) were examined for the possibility that their binding sites (idiotopes) might share structural and conformational similarity with the CD4- binding site on gp110. Polyclonal human or rabbit anti-HIV sera (that reacted with gp110 and inhibited virus binding) did not react with or inhibit the binding of these four alpha-CD4 monoclonal antibodies. Conversely, rabbit anti-idiotypic sera raised against each of the four candidate CD4 monoclonal antibodies did not react with virus or inhibit virus binding to CD4+ T cells. Further search or different approaches may yet yield an idiotype that is a structural and conformational "internal image" of the CD4-binding site of virus.
This article has been cited by other articles:
|
|
 |
|
  C. Song, K. Micoli, and E. Hunter Activity of the Mason-Pfizer Monkey Virus Fusion Protein Is Modulated by Single Amino Acids in the Cytoplasmic Tail J. Virol., September 15, 2005; 79(18): 11569 - 11579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. K. Srivastava, L. Stamatatos, E. Kan, M. Vajdy, Y. Lian, S. Hilt, L. Martin, C. Vita, P. Zhu, K. H. Roux, et al. Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate J. Virol., October 15, 2003; 77(20): 11244 - 11259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fouts, K. Godfrey, K. Bobb, D. Montefiori, C. V. Hanson, V. S. Kalyanaraman, A. DeVico, and R. Pal Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques PNAS, September 3, 2002; 99(18): 11842 - 11847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Giguere, J.-S. Paquette, S. Bounou, R. Cantin, and M. J. Tremblay New Insights into the Functionality of a Virion-Anchored Host Cell Membrane Protein: CD28 Versus HIV Type 1 J. Immunol., September 1, 2002; 169(5): 2762 - 2771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, J. Lee, E. M. Mahony, P. D. Kwong, R. Wyatt, and J. Sodroski Highly Stable Trimers Formed by Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Fused with the Trimeric Motif of T4 Bacteriophage Fibritin J. Virol., March 27, 2002; 76(9): 4634 - 4642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. K. Srivastava, L. Stamatatos, H. Legg, E. Kan, A. Fong, S. R. Coates, L. Leung, M. Wininger, J. J. Donnelly, J. B. Ulmer, et al. Purification and Characterization of Oligomeric Envelope Glycoprotein from a Primary R5 Subtype B Human Immunodeficiency Virus J. Virol., February 22, 2002; 76(6): 2835 - 2847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kim, B. Chen, R. E. Hussey, Y. Chishti, D. Montefiori, J. A. Hoxie, O. Byron, G. Campbell, S. C. Harrison, and E. L. Reinherz The Stoichiometry of Trimeric SIV Glycoprotein Interaction with CD4 Differs from That of Anti-envelope Antibody Fab Fragments J. Biol. Chem., November 9, 2001; 276(46): 42667 - 42676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, R. Wyatt, and J. Sodroski Improved Elicitation of Neutralizing Antibodies against Primary Human Immunodeficiency Viruses by Soluble Stabilized Envelope Glycoprotein Trimers J. Virol., February 1, 2001; 75(3): 1165 - 1171. [Abstract] [Full Text]
|
|
|
|
|
|
X. Yang, M. Farzan, R. Wyatt, and J. Sodroski Characterization of Stable, Soluble Trimers Containing Complete Ectodomains of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins J. Virol., June 15, 2000; 74(12): 5716 - 5725. [Abstract] [Full Text]
|
|
|
|
|
|
X. Yang, L. Florin, M. Farzan, P. Kolchinsky, P. D. Kwong, J. Sodroski, and R. Wyatt Modifications That Stabilize Human Immunodeficiency Virus Envelope Glycoprotein Trimers in Solution J. Virol., May 15, 2000; 74(10): 4746 - 4754. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Leech Molecular mimicry in autoimmune disease Arch. Dis. Child., November 1, 1998; 79(5): 448 - 451. [Full Text]
|
|
|
|
|
|
R. Bernier, B. Barbeau, M. J. Tremblay, and M. Olivier The Lipophosphoglycan of Leishmania donovani Up-Regulates HIV-1 Transcription in T Cells Through the Nuclear Factor-{kappa}B Elements J. Immunol., March 15, 1998; 160(6): 2881 - 2888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ugolini, I. Mondor, P. W.H.I. Parren, D. R. Burton, S. A. Tilley, P. J. Klasse, and Q. J. Sattentau Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line-adapted HIV-1 Neutralization J. Exp. Med., October 20, 1997; 186(8): 1287 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Berberian, L Goodglick, T. Kipps, and J Braun Immunoglobulin VH3 gene products: natural ligands for HIV gp120 Science, September 17, 1993; 261(5128): 1588 - 1591. [Abstract] [PDF]
|
|
|
|
|
|
K. Steimer, C. Scandella, P. Skiles, and N. Haigwood Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120 Science, October 4, 1991; 254(5028): 105 - 108. [Abstract] [PDF]
|
|
|
|
|
|
C. Hart, C. Ou, J. Galphin, J Moore, L. Bacheler, J. Wasmuth, S. Petteway Jr, and G Schochetman Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells Science, October 27, 1989; 246(4929): 488 - 491. [Abstract] [PDF]
|
|
|
|
|
|
M. Till, V Ghetie, T Gregory, E. Patzer, J. Porter, J. Uhr, D. Capon, and E. Vitetta HIV-infected cells are killed by rCD4-ricin A chain Science, November 25, 1988; 242(4882): 1166 - 1168. [Abstract] [PDF]
|
|
|
|
|
|
B. Jameson, P. Rao, L. Kong, B. Hahn, G. Shaw, L. Hood, and S. Kent Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein Science, June 3, 1988; 240(4857): 1335 - 1339. [Abstract] [PDF]
|
|
|
|
|
|
D. Ho, J. Kaplan, I. Rackauskas, and M. Gurney Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization Science, February 26, 1988; 239(4843): 1021 - 1023. [Abstract] [PDF]
|
|
|
|
|
|
M Kowalski, J Potz, L Basiripour, T Dorfman, W. Goh, E Terwilliger, A Dayton, C Rosen, W Haseltine, and J Sodroski Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1 Science, September 11, 1987; 237(4820): 1351 - 1355. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
